Aprea Therapeutics (APRE) Stock Price, Quote, News & History | Benzinga

Aprea Therapeutics Inc (APRE) Stock Price, Quote, News & History

APRENASDAQ

Trade with Public

Trade with Public

$0.9500

0.022.15%

At close: May 22, 5:00 PM EST

$0.9600

0.011.05%

After Hours: May 22, 7:54 PM EST

OverviewNews Earnings Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$0.90

Close

$0.95

Volume / Avg.

190.01K / 367.51K

Day Range

$0.89 - $0.97

52 Wk Range

0.55 - 2.22

Market Cap

$11.89M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

57

Short Interest

0.88%

Days to Cover

1

Recent Aprea Therapeutics Inc News

Aprea Therapeutics Advanced Cancer Trial Shows Promising Results, Stock Soars

Aprea Therapeutics shares rise after promising Phase 1 trial results with APR-1051 in cancer treatment.

Vandana Singh

Why Is Precision Oncology-Focused Aprea Therapeutics Stock Trading Higher On Monday?

FDA clearance for Aprea Therapeutics' APR-1051 IND application, a promising WEE1 kinase inhibitor. Phase 1 trial initiation in 2024, focusing on Cyclin E cancers. $34 million private placement to fund clinical development and ensure company sustainability until 2026.

Vandana Singh

Why Aprea Therapeutics Shares Hit A New 52-Week Low Today

Aprea Therapeutics Inc (NASDAQ: APRE) shares are trading lower by 17.59% to $5.20 after the company announced pricing of a $5.5 million underwritten public offering of common stock. What Else?

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-12.89M

Investing Cash Flow (TTM)

0

Financing Cash Flow (TTM)

4.64M

Free Cash Flow (TTM)

-12.89M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-8.25M

Analyst Trends and Forecast

1

Dec 25

1

Jan

1

Feb

2

Mar

2

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$34.70M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.28

Earnings Yield % (TTM)

-160.22%

Earnings Yield % (FWD)

-96.77%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.36

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$14.60M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$0.90

Close

$0.95

Volume / Avg.

190.01K / 367.51K

Day Range

$0.89 - $0.97

52 Wk Range

0.55 - 2.22

Market Cap

$11.89M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

57

Short Interest

0.88%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. It develops small molecule inhibitors designed to exploit genet...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Aprea Therapeutics (APRE) stock?

A

You can purchase shares of Aprea Therapeutics (NASDAQ:APRE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Aprea Therapeutics (APRE) competitors?

A

There are no as such competitors for Aprea Therapeutics.

Q

What is the forecast, or price target, for Aprea Therapeutics (APRE) stock?

A

Aprea Therapeutics has a consensus price target of $4.07.

Q

What is the current price for Aprea Therapeutics (APRE)?

A

The stock price for Aprea Therapeutics (NASDAQ: APRE) is $0.96 last updated May 22, 2026 at 7:54 PM EDT.

Q

Does Aprea Therapeutics (APRE) pay a dividend?

A

There are no upcoming dividends for Aprea Therapeutics.

Q

When is Aprea Therapeutics (NASDAQ:APRE) reporting earnings?

A

Aprea Therapeutics does not have any upcoming earnings scheduled.

Q

Is Aprea Therapeutics (APRE) going to split?

A

There is no upcoming split for Aprea Therapeutics.

Q

What sector and industry does Aprea Therapeutics (APRE) operate in?

A

Aprea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.